380
Views
0
CrossRef citations to date
0
Altmetric
This article refers to:
Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma

Article title: “Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma”

Authors: Alex Zhavoronkov, Evgeny Izumchenko, Riya R. Kanherkar, Mahder Teka, Charles Cantor, Kebreten Manaye, David Sidransky, Michael D. West, Eugene Makarev, and Antonei Benjamin Csoka

Journal: Cell Cycle

Bibliometrics: Volume 15, Issue 12, pages 1643–1652

DOI: 10.1080/15384101.2016.1170261

Publisher: Taylor & Francis

The author list published online in print was not in the correct order. The correct author listing is below.

Alex Zhavoronkova,b, Evgeny Izumchenkoc,†, Riya R. Kanherkard,e,†, Mahder Tekad, Charles Cantorf,g, Kebreten Manayee, David Sidranskyd, Michael D. Westh, Eugene Makareva,#, and Antonei Benjamin Csokad,e,#

aInsilico Medicine, Inc., ETC, Johns Hopkins University, Baltimore, MD, USA; bThe Biogerontology Research Foundation, London, UK; cJohns Hopkins University, Department of Otolaryngology-Head and Neck Surgery; dVision Genomics, LLC, Washington, DC, USA; eEpigenetics Laboratory, Howard University, Washington, DC, USA; fBoston University, Boston, MA, USA; gRetrotope, Inc; Los Altos Hills, CA, USA; hBioTime, Inc., Alameda, CA, USA

The online version of the article has been corrected.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.